Radiologic Diagnosis and Staging of Renal and Bladder Cancer

Seminars in Roentgenology

Volumn 41, Issue 2, 2006, Pages 121-138

  Ng, Chaan S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE DERIVATIVE; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; PETROLEUM; SOLVENT;

ADRENAL METASTASIS; ARTICLE; BLADDER CANCER; BONE METASTASIS; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY CANCER; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

EID: 33646358927     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ro.2006.02.005     Document Type: Article

References (83)

1. Jemal A., Thomas A., Murray T., et al. Cancer statistics, 2002. CA Cancer J Clin 52 1 (2002) 23-47
2. American Cancer Society (2003). Cancer Facts and Figures 2003, pp. 1-52. Atlanta, GA: American Cancer Society. Available at: http://www.cancer.org/docroot/STT/content/STT 1x Cancer Facts Figures, 2003.asp
3. Chow W.H., Devesa S.S., Warren J.L., et al. Rising incidence of renal cell cancer in the United States. JAMA 281 17 (1999) 1628-1631
4. Figlin R.A., Thompson J.A., Bukowski R.M., et al. Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. J Clin Oncol 17 8 (1999) 2521-2529
5. Pretorius E.S., Wickstrom M.L., and Siegelman E.S. MR imaging of renal neoplasms. Magn Reson Imaging Clin N Am 8 4 (2000) 813-836
6. Russo P. Renal cell carcinoma. presentation, staging, and surgical treatment. Semin Oncol 27 2 (2000) 160-176
7. Godley P., and Kim S.W. Renal cell carcinoma. Curr Opin Oncol 14 3 (2002) 280-285
8. Mostofi F.K., and Davis C.J. Histological typing of kidney tumors (1998), Springer, Berlin, New York 3-36
9. Shanks J.H. Pathology of renal cell carcinoma. recent developments. Clin Oncol (R Coll Radiol) 11 4 (1999) 263-268
10. Sobin L.H., and Wittekind C. International Union Against Cancer. TNM Classification of Malignant Tumours. (ed 5) (1997), Wiley-Liss, New York, NY 180-182
11. Reznek R.H. Renal cancer. In: Husband J.E.S., and Reznek R.H. (Eds). Imaging in Oncology (1998), Isis Medical Media, Oxford 191-214
12. Bell E.T. A classification of renal tumours with observation on the frequency of various types. J Urol 39 (1938) 238-243
13. Hafez K.S., Fergany A.F., and Novick A.C. Nephron sparing surgery for localized renal cell carcinoma. impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 162 6 (1999) 1930-1933
14. Kinouchi T., Saiki S., Meguro N., et al. Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma. Cancer 85 3 (1999) 689-695
15. Gofrit O.N., Shapiro A., and Kovalski N. Renal cell carcinoma. evaluation of the 1997 TNM system and recommendations for follow-up after surgery. Eur Urol 39 6 (2001) 669-674
16. Pantuck A.J., Zisman A., and Belldegrun A.S. The changing natural history of renal cell carcinoma. J Urol 166 5 (2001) 1611-1623
17. Delahunt B., and Eble J.N. Renal tumours. the new order. NZ Med J 111 1072 (1998) 307-309
18. Tsui K.H., Shvarts O., and Smith R.B. Prognostic indicators for renal cell carcinoma. a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 163 4 (2000) 1090-1095
19. Leibovici D., Lindner A., Sella A., et al. Novel concepts in the staging of renal cell carcinoma. Curr Urol Rep 4 1 (2003) 41-48
20. Jayson M., and Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51 2 (1998) 203-205
21. Luciani L.G., Cestari R., and Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications. study of 1092 patients (1982-1997). Urology 56 1 (2000) 58-62
22. Bosniak M.A. The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol 157 5 (1997) 1852-1853
23. Birnbaum B.A., Jacobs J.E., and Ramchandani P. Multiphasic renal CT. comparison of renal mass enhancement during the corticomedullary and nephrographic phases. Radiology 200 3 (1996) 753-758
24. Yuh B.I., and Cohan R.H. Different phases of renal enhancement. role in detecting and characterizing renal masses during helical CT. AJR Am J Roentgenol 173 3 (1999) 747-755
25. Johnson C.D., Dunnick N.R., Cohan R.H., et al. Renal adenocarcinoma. CT staging of 100 tumors. AJR Am J Roentgenol 148 (1987) 59-63
26. Hricak H., Thoeni R.F., Carroll P.R., et al. Detection and staging of renal neoplasms. a reassessment of MR imaging. Radiology 166 3 (1988) 643-649
27. Roubidoux M.A., Dunnick N.R., Sostman H.D., et al. Renal carcinoma. detection of venous extension with gradient-echo MR imaging. Radiology 182 1 (1992) 269-272
28. Welch T.J., and LeRoy A.J. Helical and electron beam CT scanning in the evaluation of renal vein involvement in patients with renal cell carcinoma. J Comput Assist Tomogr 21 3 (1997) 467-471
29. Sheth S., Scatarige J.C., Horton K.M., et al. Current concepts in the diagnosis and management of renal cell carcinoma. role of multidetector CT and three-dimensional CT. Radiographics 21 (2001) S237-S254
30. Urban B.A., Ratner L.E., and Fishman E.K. Three-dimensional volume-rendered CT angiography of the renal arteries and veins. normal anatomy, variants, and clinical applications. Radiographics 21 2 (2001) 373-386
31. Frohmuller H.G., Grups J.W., and Heller V. Comparative value of ultrasonography, computerized tomography, angiography and excretory urography in the staging of renal cell carcinoma. J Urol 138 3 (1987) 482-484
32. Habboub H.K., Abu-Yousef M.M., Williams R.D., et al. Accuracy of color Doppler sonography in assessing venous thrombus extension in renal cell carcinoma. AJR Am J Roentgenol 168 1 (1997) 267-271
33. Bos S.D., and Mensink H.J. Can duplex Doppler ultrasound replace computerized tomography in staging patients with renal cell carcinoma?. Scand J Urol Nephrol 32 2 (1998) 87-91
34. Fein A.B., Lee J.K., Balfe D.M., et al. Diagnosis and staging of renal cell carcinoma. a comparison of MR imaging and CT. AJR Am J Roentgenol 148 4 (1987) 749-753
35. Studer U.E., Scherz S., Scheidegger J., et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144 2 Pt. 1 (1990) 243-245
36. Ng C.S., Loyer E.M., Iyer R.B., et al. Metastases to the pancreas from renal cell carcinoma. findings on three-phase contrast-enhanced helical CT. AJR Am J Roentgenol 172 6 (1999) 1555-1559
37. Walter C., Kruessell M., Gindele A., et al. Imaging of renal lesions. evaluation of fast MRI and helical CT. Br J Radiol 76 910 (2003) 696-703
38. Montravers F., Grahek D., Kerrou K., et al. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med 41 1 (2000) 78-84
39. Hofer C., Kubler H., Hartung R., et al. Diagnosis and monitoring of urological tumors using positron emission tomography. Eur Urol 40 5 (2001) 481-487
40. Shvarts O., Han K.R., Seltzer M., et al. Positron emission tomography in urologic oncology. Cancer Control 9 4 (2002) 335-342
41. Hain S.F., and Maisey M.N. Positron emission tomography for urological tumours. BJU Int 92 2 (2003) 159-164
42. Ramdave S., Thomas G.W., Berlangieri S.U., et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 166 3 (2001) 825-830
43. Pashos C.L., Botteman M.F., Laskin B.L., et al. Bladder cancer. epidemiology, diagnosis, and management. Cancer Pract 10 6 (2002) 311-322
44. Mostofi F.K. Histological typing of urinary bladder tumours (1999), Springer-Verlag, Berlin, New York, NY 3-27
45. Bostwick D.G., Ramnani D., and Cheng L. Diagnosis and grading of bladder cancer and associated lesions. Urol Clin North Am 26 3 (1999) 493-507
46. Husband J.E. Bladder cancer. In: Husband J.E.S., and Reznek R.H. (Eds). Imaging in Oncology (1998), Isis Medical Media, Oxford 215-238
47. Oosterlinck W., Lobel B., Jakse G., et al. Guidelines on bladder cancer. Eur Urol 41 2 (2002) 105-112
48. Gschwend J.E., Dahm P., and Fair W.R. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41 4 (2002) 440-448
49. Kantoff P.W., Zeitman A.L., and Wishnow K. Bladder cancer. In: Bast R.C., Kufe D.W., Pollock R.E., et al. (Eds). Cancer Medicine (2000), BC, Decker Inc, Hamilton, Ontario 1543-1558
50. Jewett H., and Strong G. Infiltrating carcinoma of the bladder. relation of depth of penetration of the bladder wall to incidence of local extension in metastases. J Urol 55 (1946) 366-372
51. Marshall V.F. The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 68 (1952) 714-723
52. Whitmore Jr. W.F. Assessment and management of deeply invasive and metastatic lesions. Cancer Res 37 8 Pt. 2 (1977) 2756-2758
53. Levy D.A., and Grossman H.B. Staging and prognosis of T3b bladder cancer. Semin Urol Oncol 14 2 (1996) 56-61
54. Barentsz J.O., Jager G.J., and Witjes J.A. MR imaging of the urinary bladder. Magn Reson Imaging Clin N Am 8 4 (2000) 853-867
55. Vock P., Haertel M., Fuchs W.A., et al. Computed tomography in staging of carcinoma of the urinary bladder. Br J Urol 54 2 (1982) 158-163
56. Sager E.M., Talle K., Fossa S., et al. The role of CT in demonstrating perivesical tumor growth in the preoperative staging of carcinoma of the urinary bladder. Radiology 146 2 (1983) 443-446
57. Fisher M.R., Hricak H., and Crooks L.E. Urinary bladder MR imaging. Part I. Normal and benign conditions. Radiology 157 2 (1985) 467-470
58. Fisher M.R., Hricak H., and Tanagho E.A. Urinary bladder MR imaging. Part II. Neoplasm. Radiology 157 2 (1985) 471-477
59. Amendola M.A., Glazer G.M., Grossman H.B., et al. Staging of bladder carcinoma. MRI-CT-surgical correlation. AJR Am J Roentgenol 146 6 (1986) 1179-1183
60. Rholl K.S., Lee J.K., Heiken J.P., et al. Primary bladder carcinoma. evaluation with MR imaging. Radiology 163 1 (1987) 117-121
61. Buy J.N., Moss A.A., Guinet C., et al. MR staging of bladder carcinoma. correlation with pathologic findings. Radiology 169 3 (1988) 695-700
62. Koelbel G., Schmiedl U., Griebel J., et al. MR imaging of urinary bladder neoplasms. J Comput Assist Tomogr 12 1 (1988) 98-103
63. Husband J.E., Olliff J.F., Williams M.P., et al. Bladder cancer. staging with CT and MR imaging. Radiology 173 2 (1989) 435-440
64. Neuerburg J.M., Bohndorf K., Sohn M., et al. Urinary bladder neoplasms. evaluation with contrast-enhanced MR imaging. Radiology 172 3 (1989) 739-743
65. Tavares N.J., Demas B.E., and Hricak H. MR imaging of bladder neoplasms. correlation with pathologic staging. Urol Radiol 12 1 (1990) 27-33
66. Tachibana M., Baba S., Deguchi N., et al. Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder. a comparative study with computerized tomography and transurethral ultrasonography. J Urol 145 6 (1991) 1169-1173
67. Tanimoto A., Yuasa Y., Imai Y., et al. Bladder tumor staging. comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Radiology 185 3 (1992) 741-747
68. Doringer E. Computerized tomography of colonic diverticulitis. Crit Rev Diagn Imaging 33 5 (1992) 421-435
69. Kim B., Semelka R.C., Ascher S.M., et al. Bladder tumor staging. comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 193 1 (1994) 239-245
70. Barentsz J.O., Jager G., Mugler III J.P., et al. Staging urinary bladder cancer. value of T1-weighted three-dimensional magnetization prepared-rapid gradient-echo and two-dimensional spin-echo sequences. AJR Am J Roentgenol 164 1 (1995) 109-115
71. Barentsz J.O., Jager G.J., van Vierzen P.B., et al. Staging urinary bladder cancer after transurethral biopsy. value of fast dynamic contrast-enhanced MR imaging. Radiology 201 1 (1996) 185-193
72. Barentsz J.O., Witjes J.A., and Ruijs J.H. What is new in bladder cancer imaging. Urol Clin North Am 24 3 (1997) 583-602
73. MacVicar A.D. Bladder cancer staging. BJU Int 86 suppl 1 (2000) 111-122
74. Caterino M., Finocchi V., Giunta S., et al. Bladder cancer within a direct inguinal hernia. CT demonstration. Abdom Imaging 26 6 (2001) 664-666
75. Koss J.C., Arger P.H., Coleman B.G., et al. CT staging of bladder carcinoma. AJR Am J Roentgenol 137 2 (1981) 359-362
76. Husband J.E. Computer tomography and magnetic resonance imaging in the evaluation of bladder cancer. J Belge Radiol 78 6 (1995) 350-355
77. Jager G.J., Barentsz J.O., Oosterhof G.O., et al. Pelvic adenopathy in prostatic and urinary bladder carcinoma. MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 167 6 (1996) 1503-1507
78. Fielding J.R., Hoyte L.X., Okon S.A., et al. Tumor detection by virtual cystoscopy with color mapping of bladder wall thickness. J Urol 167 2 Pt. 1 (2002) 559-562
79. McTavish J.D., Jinzaki M., Zou K.H., et al. Multi-detector row CT urography. comparison of strategies for depicting the normal urinary collecting system. Radiology 225 3 (2002) 783-790
80. Lammle M., Beer A., Settles M., et al. Reliability of MR imaging-based virtual cystoscopy in the diagnosis of cancer of the urinary bladder. AJR Am J Roentgenol 178 6 (2002) 1483-1488
81. Herts B.R. The current status of CT urography (2002). Crit Rev Comput Tomogr 43 3 (2002) 219-241
82. Gray Sears C.L., Ward J.F., Sears S.T., et al. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J Urol 168 6 (2002) 2457-2460
83. Williams S.G., Buscarini M., and Stein J.P. Molecular markers for diagnosis, staging, and prognosis of bladder cancer. Oncology (Williston Park) 15 11 (2001) 1461-1470 1473-1474, 1476; discussion 1476-1484